has been studied in severe asthmatics and in COPD patients with a history of asthma, showing an additional bronchodilator effect on top of the current asthma treatment. The first large study on ...
but the new formulation will allow patients to take greater control of their treatment. Like its predecessor, it is approved in the EU for use in patients 12 years and older with severe asthma who ...
The first-in class medicine for severe asthma co-developed ... of asthma exacerbations and uncontrolled asthma receiving currently approved inhaled treatment versus placebo. The trial showed ...
A study shows that of the one in eight children in several African countries who have asthma, the vast majority are undiagnosed and therefore untreated.